| Title | Overview of the 3rd isirv-Antiviral Group Conference--advances in clinical management. | ||
| Author | Hurt, Aeron C; Hui, David S; Hay, Alan; Hayden, Frederick G | ||
| Journal | Influenza Other Respir Viruses | Publication Year/Month | 2015-Jan |
| PMID | 25399715 | PMCID | PMC4280814 |
| Affiliation | 1.WHO Collaborating Centre for Reference and Research on Influenza, VIDRL at the Peter Doherty Institute for Infection and Immunity, Parkville, Vic., Australia; Melbourne School of Population and Global Health, University of Melbourne, Parkville, Vic., Australia. | ||
This review highlights the main points which emerged from the presentations and discussions at the 3rd isirv-Antiviral Group Conference - advances in clinical management. The conference covered emerging and potentially pandemic influenza viruses and discussed novel/pre-licensure therapeutics and currently approved antivirals and vaccines for the control of influenza. Current data on approved and novel treatments for non-influenza respiratory viruses such as MERS-CoV, respiratory syncytial virus (RSV) and rhinoviruses and the challenges of treating immunocompromised patients with respiratory infections was highlighted.